|
Tuesday, May 8, 2012
Marsha Millonig, M.B.A., B.S. Pharm.
, Catalyst Enterprises, LLC
Title: President and CEO
Presentation Title: Medication Therapy Management: State of the Industry
Track Date: 5/8/2012 2:15:00 PM
Marsha Millonig is the president and CEO of Catalyst Enterprises, LLC, a healthcare consulting firm dedicated to creating change toward improved health outcomes. Previously, she was with the Healthcare Distribution Management Association (HDMA), and the National Association of Chain Drug Stores (NACDS.) She is a practicing pharmacist and pharmacist immunizer. Her latest work, “100 MTM Tips for Pharmacists” was published by, and is available through, APhA.
Presentation Summary:
Hear a “state of the industry” of medication therapy management (MTM) services with five-year trend data on MTM service provisions from provider, payer, and consumer perspectives. You’ll learn how providers and payers determine service offerings and measure their value, how implementation strategies are evolving, what barriers continue to be encountered, and how integration is coming along within the evolving electronic health record (EHR) and health information exchange (HIE) environment.
[Back to Agenda]
|
Don Bell, Esq.
, National Association of Chain Drug Stores
Title: Senior Vice President and General Counsel
Presentation Title: Beyond AWP: Implementing New and Improved Pricing Benchmarks
Track Date: 5/8/2012 2:15:00 PM
Don Bell is senior vice president and general counsel for the National Association of Chain Drug Stores (NACDS). He advises NACDS and chain pharmacies regarding federal drug laws, Medicare and Medicaid reimbursement, fraud and abuse laws, antitrust, employment law, and many other legal issues that affect NACDS and its members. He is also responsible for managing ongoing litigation on behalf of chain pharmacies. He regularly gives presentations and writes articles on legislation, litigation and regulations that affect the pharmaceutical industry. Bell has been awarded designation as a Certified Association Executive by the American Society for Association Executives, and he has served as president of the American Society for Pharmacy Law.
Presentation Summary:
The pharmaceutical industry is undergoing a benchmarking revolution. New benchmarks such as average acquisition cost (AAC) and national average drug acquisition cost (NADAC) are being developed to reflect actual drug costs. Average manufacturer’s price (AMPs) and federal upper limits (FULs) are being substantially revised to comply with new standards. Other benchmarks such as retail selling price (RSP), average selling price (ASP), and wholesale acquisition cost (WAC) are undergoing changes and new uses due to new standards, lawsuits, and reduced reliance on average wholesale price. Implementing this benchmarking revolution poses unique challenges for business practices and systems. This session will explain each benchmark, discuss how benchmarks may be implemented in accordance with industry standards and practices, and review the impact this benchmarking revolution may have on industry participants.
[Back to Agenda]
|
Marc Nyarko (co-presenter)
, Humana
Title: Director of Operations
Presentation Title: Taking the Next Step: ePrior Auth at the Point of Care
Track Date: 5/8/2012 2:15:00 PM
Marc Nyarko has over 14 years of healthcare experience in implementing effective operational programs. Since joining Humana in 1997, he has spearheaded creative technology solutions that have gleaned far-reaching operational results. In his current role, he is leading the company’s commercial, Part D, and Part B Coverage Determination operations.
Presentation Summary:
This is a perspective from the industry on interoperability among a health plan, pharmacy benefit manager (PBM), point of care vendor, and physicians for electronic prior authorization, including success stories and challenges. The presentation will include a success story of health plan integration and collaboration, working with point of care vendors and their provider community to roll out the capability of prior authorization at point of care, as well as examples of collaboration among several entities towards a common vision.
[Back to Agenda]
|
Cami Agena, Esq. (co-presenter)
, The Phoenix Law Group
Title: Attorney
Presentation Title: A Recap of 2011 and A Look at What's Coming: A Legal Update for PBMs and Pharmacies
Track Date: 5/8/2012 1:00:00 PM
Cami Agena is a 1995 graduate of the Arizona State University College of Law and has been a pharmacy benefit management (PBM) lawyer since 1997. After being an in-house PBM attorney for more than five years, she joined The Phoenix Law Group and now advises clients in the areas of regulatory compliance; Medicare Part D; pharmacy, client, rebate and vendor contracting; licensing; and eBusiness and ePrescribing.
Presentation Summary:
You will hear an update of the newest laws and regulations that affect PBMs, pharmacies, and others involved in prescription benefits. The update includes such laws as provider mandates and contracting, prompt pay, discount cards, benefit mandates, HIPAA, licensing (PBM, mail order pharmacy, internet pharmacy, third party administration, utilization review, and preferred provider organizations), disease management, formulary management, and therapeutic interchange, among others.
[Back to Agenda]
|
Samantha Brown, Esq.(co-presenter)
, The Phoenix Law Group
Title: Attorney
Presentation Title: A Recap of 2011 and A Look at What's Coming: A Legal Update for PBMs and Pharmacies
Track Date: 5/8/2012 1:00:00 PM
Samantha Brown is a 1991 graduate of the University of Missouri, Kansas City School of Law and has been a pharmacy benefit management (PBM) lawyer since 1998. After being an in-house PBM attorney for more than four years, she helped found The Phoenix Law Group and now advises clients in the areas of regulatory compliance; Medicare Part D; pharmacy, client and vendor contracting; licensing; and mail and retail pharmacy operations.
Presentation Summary:
You will hear an update of the newest laws and regulations that affect PBMs, pharmacies, and others involved in prescription benefits. The update includes such laws as provider mandates and contracting, prompt pay, discount cards, benefit mandates, HIPAA, licensing (PBM, mail order pharmacy, internet pharmacy, third party administration, utilization review, and preferred provider organizations), disease management, formulary management, and therapeutic interchange, among others.
[Back to Agenda]
|
Damon Tressler (co-presenter)
, CVS Caremark
Title: Director, Industry Standards, Systems & Practices
Presentation Title: D.0 - Do's, Don'ts and Dependencies in an Era of Healthcare Reform
Track Date: 5/8/2012 1:00:00 PM
Damon Tressler has been employed at CVS Caremark for the past 17 years, and a member of NCPDP since 1999. In his current position of director, industry standards, systems & practices; he is responsible for representing CVS Caremark at industry standard settings, managing the relationship with pharmacy provider networks and software vendors related to technical and administrative capabilities, as well as coordinating CVS Caremark new products and system enhancements so they are designed to work within industry standards, practices and compliance.
Presentation Summary:
Explore the successes and challenges during the retail pharmacy’s industry move from NCPDP’s 5.1 standard to the D.Ø standard. What did we do right? What did we do wrong? What are some possible recommendations going forward? During the presentation, panel members will highlight specific items that would be beneficial to include in the next version(s) to address omissions and how the continued evolution of healthcare reform will likely affect industry standards. In addition, panel members will share their experiences related to key areas such as partner readiness, certification, roll-out and change control.
[Back to Agenda]
|
L. Paul Hooper, MBA (co-presenter)
, Emdeon, Inc.
Title: Vice President, Pharmacy Network Services
Presentation Title: D.0 - Do's, Don'ts, and Dependencies in an Era of Healthcare Reform
Track Date: 5/8/2012 1:00:00 PM
L. Paul Hooper directs Emdeon’s network services initiatives with a focus on developing innovative programs, standards and partnerships to provide retail pharmacy solutions. He has spent over 25 years in a variety of roles in product development, systems, finance and operations. He has worked at various recognized industry leaders: BASF, Abbott Laboratories, Cardinal Health, and ArcLight. Hooper is active with various work groups and task groups within NCPDP and a member of Belmont University’s School of Pharmacy External Advisory Council. He holds a M.B.A. from Ohio University and a B.S. in Food Science from Pennsylvania State University.
Presentation Summary:
Explore the successes and challenges during the retail pharmacy’s industry move from NCPDP’s 5.1 standard to the D.Ø standard. What did we do right? What did we do wrong? What are some possible recommendations going forward? During the presentation, panel members will highlight specific items that would be beneficial to include in the next version(s) to address omissions and how the continued evolution of healthcare reform will likely affect industry standards. In addition, panel members will share their experiences related to key areas such as partner readiness, certification, roll-out and change control.
[Back to Agenda]
|
Lathe Bigler
, Emdeon
Title: Senior Director, Clinical Services
Presentation Title: The Essential Value of HIEs and ACOs in Delivering Patient-Centered Pharmacy Care
Track Date: 5/8/2012 1:00:00 PM
Lathe Bigler is currently the senior director, clinical services for Emdeon. In his current role, he is responsible for leading Emdeon’s eRx Network services that support retail pharmacies in ePrescribing. He has held various roles within healthcare management for the past 13 years in areas including electronic health records, medical device manufacturing and ePrescribing systems.
Presentation Summary:
Health Information Exchanges (HIEs) are becoming an important part in the delivery of patient health information across multiple heath systems and technology platforms. This presentation will discuss the benefits of how HIEs operate and how Master Patient Index (MPI) technology is being used to support the industry’s pursuit of providing quality patient-centric care. This includes the delivery of patient medication history. MPI technology provides opportunities for multiple end points to request/receive patient-centric data from multiple internal and external sources. This technology will be the conduit for pharmacies to share medication history with other healthcare providers to improve decision support and decrease prescription errors and hospital readmissions. This presentation will provide an overview of how HIEs and MPI technology will support interoperability and the access of information across many networks within healthcare.
[Back to Agenda]
|
Scot Lovejoy, R.Ph. (co-presenter)
, Agadia Systems, Inc.
Title: Chief Pharmacy Officer
Presentation Title: Taking the Next Step: ePrior Auth at the Point of Care
Track Date: 5/8/2012 2:15:00 PM
Scot Lovejoy is a pharmacist with 30 years of pharmacy and pharmacy benefit management (PBM) industry experience, including developing, enhancing, and implementing mission critical processes and clinical and operational systems and programs. He currently serves as the chief pharmacy officer and privacy officer for Agadia Systems, Inc. where he provides clinical and operational leadership.
Presentation Summary:
This is a perspective from the industry on interoperability among a health plan, pharmacy benefit manager (PBM), point of care vendor, and physicians for electronic prior authorization, including success stories and challenges. The presentation will include a success story of health plan integration and collaboration, working with point of care vendors and their provider community to roll out the capability of prior authorization at point of care, as well as examples of collaboration among several entities towards a common vision.
[Back to Agenda]
|
Wayne Armstrong (co-presenter)
, Argus Health Systems, Inc.
Title: Senior Vice President
Presentation Title: Taking the Next Step: ePrior Auth at the Point of Care
Track Date: 5/8/2012 2:15:00 PM
Wayne Armstrong has provided operational and IT consulting for numerous internationally recognized organizations, during his more than 40 years in business and technology. His knowledge of healthcare and system design has been an asset to new product development for Argus since 1995 and he currently leads the company’s research efforts in product planning.
Presentation Summary:
This is a perspective from the industry on interoperability among a health plan, pharmacy benefit manager (PBM), point of care vendor, and physicians for electronic prior authorization, including success stories and challenges. The presentation will include a success story of health plan integration and collaboration, working with point of care vendors and their provider community to roll out the capability of prior authorization at point of care, as well as examples of collaboration among several entities towards a common vision.
[Back to Agenda]
|
Ben Loy, R.Ph. (co-presenter)
, PDX
Title: Sr, Vice President of Industry Relations
Presentation Title: D.0 - Do's, Don'ts and Dependencies in an Era of Healthcare Reform
Track Date: 5/8/2012 1:00:00 PM
Ben Loy has held his current position for the past 11 years and works primarily with vendors and business partners that integrate with the PDX pharmacy management systems. Duties include working with national organizations such as NCPDP, National Community Pharmacists Association, National Association of Chain Drug Stores, Food Marketing Institute, and providing input to the support, development and management teams. His duties at PDX have taken him into government relations and regulatory compliance.
Presentation Summary:
Explore the successes and challenges during the retail pharmacy’s industry move from NCPDP’s 5.1 standard to the D.Ø standard. What did we do right? What did we do wrong? What are some possible recommendations going forward? During the presentation, panel members will highlight specific items that would be beneficial to include in the next version(s) to address omissions and how the continued evolution of healthcare reform will likely affect industry standards. In addition, panel members will share their experiences related to key areas such as partner readiness, certification, roll-out and change control.
[Back to Agenda]
|
Wednesday, May 9, 2012
Kay Morgan (co-presenter)
, Elsevier / Gold Standard
Title: Senior Vice President Drug Products and Industry Standards
Presentation Title: NCPDP Solutions and Benefits for Pharmaceutical Manufacturers
Track Date: 5/9/2012 10:30:00 AM
Kay Morgan is currently senior vice president of drug products and industry standards for Gold Standard, an Elsevier company. Her responsibilities include product content for Gold Standard products and reviewing existing and new Gold Standard products for compliance with industry standards. Previously, Morgan served Gold Standard as vice president, drug product pricing. Prior to joining Gold Standard, she was the manager of product knowledge base services with First Databank, where she managed the U.S. pricing file, a component of the National Drug Data File. Morgan previously held several positions with Abbott Laboratories, including manager of trade relations and third party payers, as well as manager of product information. Morgan received her bachelor of science in pharmacy from the University of Missouri, where she is an active participant of the Dean’s Advisory Council. Morgan has been a member of NCPDP since 1988 and is currently co-chair for WG2 Product Identification and a former NCPDP co-chair for WG15 Sample Management and Activity Reporting Transactions for Safety (retired) and past member of the NCPDP Board of Trustees.
Presentation Summary:
With ever changing regulations and compliance requirements, pharmaceutical manufacturers are increasingly challenged in effectively managing information about their channels, customers, sales, and discounts. NCPDP, a not-for-profit ANSI-Accredited Standards Development Organization, has developed various standards and data solutions that can facilitate improved information management for manufacturers. NCPDP work groups work on standards to improve pharmaceutical manufacturer rebate processing, formulary and benefit information, pharmaceutical pedigree & traceability, and product identification among others. In addition, NCPDP’s data products such as dataQ® 3.0 and HCIdea® 3.0 can assist manufacturers in better managing their pharmacy and prescriber databases.
[Back to Agenda]
|
Dave Marotz (co-presenter)
, Surescripts
Title: Product Manager of EPCS
Presentation Title: ePrescribing of Controlled Substances: The Real World
Track Date: 5/9/2012 9:15:00 AM
Dave Marotz is product manager of Electronic Prescription of Controlled Substances (EPCS) in the product management business of Surescripts. David’s eight-plus years primarily focused in healthcare with FDA, CE regulations and mandates, Health Level 7 v2 messaging and v3 modeling experience. He holds a bachelor of arts in economics and minor in management from St. Olaf College.
Presentation Summary:
The Drug Enforcement Agency (DEA) published the Interim Final Rule (IFR) for ePrescribing of Controlled Substances (EPCS) over two years ago. Since that original publication thousands of hours from EPCS adopting organizations have been put into analysis, development, implementation, certification, and third party auditing to meet the requirements outlined by the DEA. This session will provide an overview of the industry experience implementing to meet the IFR and its impacts on the industry; ePrescribing systems, prescribers, pharmacists to enable all prescribing to occur electronically – and what we have seen to date for adoption, workflow and impacts.
[Back to Agenda]
|
Mike Etreby (co-presenter)
, Cerner Etreby
Title: Director, Solution Management Cerner Etreby
Presentation Title: ePrescribing of Controlled Substances: The Real World
Track Date: 5/9/2012 9:15:00 AM
Mike Etreby is the former co-founder and CEO of Etreby Computer Company, founded in 1982 and acquired in 2007 by Cerner Corporation, the largest company in the world focused on healthcare IT. Etreby stayed with Cerner after the acquisition as a consultant and recently as a full-time associate responsible for retail pharmacy solution management. Cerner Etreby continues to be a leading software solutions provider to retail and health systems pharmacies. Etreby holds a bachelor’s degree in electrical engineering from the University of Cairo and a master’s degree in computer engineering from California State University in Los Angeles.
Presentation Summary:
The Drug Enforcement Agency (DEA) published the Interim Final Rule (IFR) for ePrescribing of Controlled Substances (EPCS) over two years ago. Since that original publication thousands of hours from EPCS adopting organizations have been put into analysis, development, implementation, certification, and third party auditing to meet the requirements outlined by the DEA. This session will provide an overview of the industry experience implementing to meet the IFR and its impacts on the industry; ePrescribing systems, prescribers, pharmacists to enable all prescribing to occur electronically – and what we have seen to date for adoption, workflow and impacts.
[Back to Agenda]
|
Doug Long, M.B.A.
, IMS Health
Title: Vice President Industry Relations
Presentation Title: The US Pharmaceutical Market: Looking Back and Looking Ahead!
Track Date: 5/9/2012 8:00:00 AM
Doug Long is vice president of industry relations at IMS Health, the world’s largest pharmaceutical information company. IMS Health provides consulting services and an extensive product portfolio to the pharmaceutical industry in more than 101 countries worldwide. Since joining IMS in 1989, he has been active in the successful implementation of data health databases and has a unique perspective on the changing U.S. and global healthcare marketplace and pharmaceutical distribution. His “Industry Year in Review” features trends and forecasts of the U.S. market. Wholesalers, retailers, manufacturers, and multiple trade associations rely on him for guidance, direction and industry expertise. He is a frequent industry speaker and permanent member of the Editorial Advisory Board of HealthCare Distributor magazine. He was a recipient of the 2004 Nexus Award for Lifetime Achievement and IMS’ prestigious Summit Award in 2003. Prior to IMS Health, he was at Nielsen Market Research for sixteen years in sales and marketing capacities.
Presentation Summary:
The U.S. remains the largest and most attractive market in the world, with sales of over $300 billion. But growth is slowing, and companies are turning to faster-growing emerging markets. The challenges of managing growth in the U.S. have shifted attention toward re-tooling research and development, understanding consumers and physicians better, working with commercial payers, and dealing with regulatory action. We will explore expectations for 2012, examining key events, accelerators and suppressors of growth, and their potential impact on the market.
[Back to Agenda]
|
Tracey McCutcheon, M.H.S.A., M.B.A.
, Centers for Medicare and Medicaid Services
Title: Deputy Director, Medicare Drug Benefit and C&D Data Group
Presentation Title: CMS Call Letter and Other Part D Happenings
Track Date: 5/9/2012 9:15:00 AM
Tracey McCutcheon is deputy director of the Medicare Drug Benefit and C & D Data Group at the Centers for Medicare and Medicaid Services (CMS). She earned Master of Health Services Administration (MHSA) and MBA (finance) degrees from George Washington University, and worked in the private healthcare sector before joining CMS in 2003. Private sector experience includes operational management in both health maintenance and disease management organizations, as well as internal auditing and general management in a multi-institutional healthcare delivery system. Following passage of the Medicare Modernization Act, she coordinated the policy development for and drafting of the Medicare Prescription Drug Benefit regulations, and directed ongoing policy development for the Part D program. In her current role, she continues to work on Part D policy development and assists with direction of the divisions responsible for Part D plan contracting, performance and quality measurement and monitoring, formulary and benefit package review, Part C and D data collection and analysis, the coverage gap discount program, and health plan management system (HPMS) and true out-of-pocket costs (TrOOP) facilitation systems management. McCutcheon has been a member of NCPDP since 2005 and continues to collaborate with Part D sponsors, the pharmacy industry and other stakeholders to assist development of standardized processes to manage new business requirements introduced by Medicare Part D.
Presentation Summary:
The Affordable Care Act and other very recent CMS guidance create changes in Part D coverage and benefit administration rules for coverage years 2013 and beyond. These include changes to the definition of Part D drugs, to the administration of the coverage gap discount program, and to sponsor responsibility for drug utilization review to better control for overutilization of opioids. Other changes improve transparency around sponsor quality and performance ratings, pharmacy network contracting arrangements and prescriber identification.
[Back to Agenda]
|
Adam Kroetsch (co-presenter)
, U.S. Food and Drug Administration
Title: Operations Research Analyst
Presentation Title: Promoting Safe Use of Drugs: Collaboration Between FDA and NCPDP
Track Date: 5/9/2012 10:30:00 AM
Adam Kroetsch is an Operations Research Analyst in the Office of Planning and Informatics at FDA. He has been closely involved in a number of efforts to help better integrate REMS into the healthcare delivery system and to better measure REMS’ effectiveness.
Presentation Summary:
This presentation will describe existing and potential areas for collaboration with NCPDP. This will include a discussion of the FDA’s work with NCPDP to incorporate Risk Evaluation and Mitigation Strategies (REMS) into existing ePrescribing and Telecommunications standards, efforts to improve prescription container labels for medicines containing acetaminophen, and the distribution of Patient Medication Information (PMI).
[Back to Agenda]
|
John Foley
, John Foley Inc.
Title: Moticational Speaker
Presentation Title: Keynote Speaker
Track Date: 5/9/2012 1:00:00 PM
A former lead solo pilot for the Blue Angels, motivational speaker John Foley is an expert on teamwork in intense, high-stakes environments. As the leader of the Navy's elite precision exhibition flying team, Foley expected unparalleled levels of excellence from his team and required steadfast commitment, discipline, and trust in order to reach peak performance levels. With insight from the Blue Angels, lessons from the Stanford Graduate School of Business, and his experiences in the inner circle of a venture capital company, John Foley has developed a practical, effective model for developing a high performance team. Delivering the "wow and how" of high performance, his customized multimedia presentations bring the goods your organization needs to close performance gaps and create a culture of excellence.
Presentation Summary:
Don't miss John Foley and learn why the Blue Angels are in the top 1/10th of 1/10th of 1 percent of all pilots--how they get there, how they stay there, and how you and your teams can translate those secrets into your organization.
[Back to Agenda]
|
Cynthia Fitzpatrick, B.S.N. (co-presenter)
, U.S. Food and Drug Administration
Title: Project Manager
Presentation Title: Promoting Safe Use of Drugs: Collaboration Between FDA and NCPDP
Track Date: 5/9/2012 10:30:00 AM
Cindi Fitzpatrick works on the Safe Use Initiative, a non-regulatory initiative in the Food and Drug Administration’s center for drugs that facilitates public/private collaborations to reduce preventable harm from medicines. Acetaminophen is one of her areas of focus. Fitzpatrick serves on the NCPDP Acetaminophen Best Practices Task Group and as an advisor to the Acetaminophen Awareness Coalition and other initiatives intended to improve the safe use of acetaminophen. She held clinical research and nursing positions before coming to FDA in 2000 as a consumer safety officer. Throughout her career, she has advocated for the use of plain language and health literacy principles in communications.
Presentation Summary:
This presentation will describe existing and potential areas for collaboration with NCPDP. This will include a discussion of FDA’s work with NCPDP to incorporate Risk Evaluation and Mitigation Strategies (REMS) into existing ePrescribing and telecommunication standards, efforts to improve prescription container labels for medicines containing acetaminophen, and the distribution of Patient Medication Information (PMI).
[Back to Agenda]
|
Bryon Pearsall, Esq. R.Ph.(co-presenter)
, U.S. Food and Drug Administration
Title: Health Scientist Policy Analyst
Presentation Title: Promoting Safe Use of Drugs: Collaboration Between FDA and NCPDP
Track Date: 5/9/2012 10:30:00 AM
Bryon Pearsall is a health scientist policy analyst for the Division of Medical Policy Programs in the Office of Medical Policy Initiatives. He is one of the leads on FDA’s Patient Medication Information initiative. Pearsall has over 15 years of professional work experience in the pharmaceutical and legal fields including experience as a retail pharmacist, a litigation drug safety team lead, a pharmacovigilance alliance manager, and a medical malpractice attorney.
Presentation Summary:
This presentation will describe existing and potential areas for collaboration with NCPDP. This will include a discussion of FDA’s work with NCPDP to incorporate Risk Evaluation and Mitigation Strategies (REMS) into existing ePrescribing and telecommunication standards, efforts to improve prescription container labels for medicines containing acetaminophen, and the distribution of Patient Medication Information (PMI).
[Back to Agenda]
|
Steve Drucker, Jr. ,M.S. (co-presenter)
, Merck and Co., Inc.
Title: Director, Global Pharmaceutical Commercialization
Presentation Title: NCPDP Solutions and Benefits for Pharmaceutical Manufacturers
Track Date: 5/9/2012 10:30:00 AM
Steve Drucker is director, global pharmaceutical commercialization packaging technology. He manages global regulatory compliance and distribution support for Merck. He is responsible for strategies and tactics around implementation of new compliance technologies with a focus on security measures (e.g. serialization, anti-counterfeit, etc.) and cold chain technologies. Drucker has over 30 years in the pharmaceutical industry working in package development, package engineering, validation and quality. He has worked for Boehringer Ingelheim, Warner Lambert/Pfizer, and Hoffmann-LaRoche. He received a B.A. in industrial management from Western Connecticut State University and a M.S. in packaging science from Rochester Institute of Technology. He was a Certified Packaging Professional (CPP). Drucker has been involved in a number of initiatives such as contributing the packaging portion of the ISPE Good Practice Guide: Technology Transfer. He is a current WG17 Pharmaceutical Pedigree and Traceability co-chair, and has been involved with the International Society for Pharmaceutical Engineers (ISPE), EPCglobal/GS1, Pharmaceutical Manufacturers Association (PhRMA) and European Federation of Pharmaceutical Industries and Associations (EFPIA) on counterfeiting and security topics. He has also been involved with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on vaccine packaging.
Presentation Summary:
With ever changing regulations and compliance requirements, pharmaceutical manufacturers are increasingly challenged in effectively managing information about their channels, customers, sales, and discounts. NCPDP, a not-for-profit ANSI-Accredited Standards Development Organization, has developed various standards and data solutions that can facilitate improved information management for manufacturers. NCPDP work groups work on standards to improve pharmaceutical manufacturer rebate processing, formulary and benefit information, pharmaceutical pedigree & traceability, and product identification among others. In addition, NCPDP’s data products such as dataQ® 3.0 and HCIdea® 3.0 can assist manufacturers in better managing their pharmacy and prescriber databases.
[Back to Agenda]
|
Lucy Yun Lu, Pharm. D., M.S., B.C.P.S.
, Hennepin County Medical Center
Title: Clinical Associate Professor
Presentation Title: Skilled Nursing Facility (SNF) Medication Reconciliation for Discharge
Track Date: 5/9/2012 9:15:00 AM
Lucy Yun Lu is a first, second and third phase leadership committee member for work-flow design, data collection and analysis. She is the first pharmacist to pilot this project and provided first-hand database to executive committee.
Presentation Summary:
Hennepin County Medical Center piloted a multi-disciplinary, closed-loop discharge process involving physicians, nurse coordinators, and clinical pharmacists to reduce medication errors. In the pilot phase the discharge medication error rate was reduced from 92% to essentially 0%. In the intervention group, the 30-day related readmission rate for Minor, Moderate, and Severe severity of illness (SOI) was 5.4% (4/74), compared to 9.5% (169/1780) in the control group. Upon expanding the process hospital-wide, Hennepin County Medical Center has maintained its related readmission rate at 6.7% (29.5% reduction). By implementing a team approach for discharge order reconciliation that included a pharmacist review, Hennepin County Medical Center reduced discharge medication errors and improved its related readmission rate.
[Back to Agenda]
|
Peter Kaufman, M.D. (co-presenter)
, DrFirst, Inc.
Title: Chief Medical Officer
Presentation Title: ePrescribing of Controlled Substances: The Real World
Track Date: 5/9/2012 9:15:00 AM
Schooled at MIT, Dr. Kaufman nurtured a strong interest in medical informatics while a Bowman Gray School of Medicine faculty member. After entering private practice he founded PiNK software in 1996 to produce electronic medical record (EMR) software, later becoming DrFirst’s chief medical officer upon its founding in 1999. He lectures nationally on various healthcare IT topics and continues a limited clinical practice as a board-certified gastroenterologist. Representing the American Gastroenterological Association, Dr. Kaufman is a delegate to the AMA and was co-chair of the Physicians Electronic Health Record Consortium (PEHRC). Work Group participation includes CCHIT (stand-alone ePrescribing), HIMSS (ePrescribing), and NCPDP (ePrescribing).
Presentation Summary:
The Drug Enforcement Agency (DEA) published the Interim Final Rule (IFR) for ePrescribing of Controlled Substances (EPCS) over two years ago. Since that original publication thousands of hours from EPCS adopting organizations have been put into analysis, development, implementation, certification, and third party auditing to meet the requirements outlined by the DEA. This session will provide an overview of the industry experience implementing to meet the IFR and its impacts on the industry; ePrescribing systems, prescribers, pharmacists to enable all prescribing to occur electronically – and what we have seen to date for adoption, workflow and impacts.
[Back to Agenda]
|
Bob Matsuk, R.Ph., M.B.A. (co-presenter)
, HighPoint Solutions
Title: Chief Strategy Officier
Presentation Title: NCPDP Solutions and Benefits for Pharmaceutical Manufacturers
Track Date: 5/9/2012 10:30:00 AM
Bob Matsuk is the chief strategy officer at HighPoint Solutions, an IT consulting company focused on the life sciences and healthcare industries. In his current role, he is responsible for the overall corporate strategy of the organization. As a volunteer for NCPDP, Matsuk co-chairs WG7 Manufacturer Rebates, which leads the development and ongoing maintenance of data standards for rebate management between pharmaceutical manufacturers and payers.
Presentation Summary:
With ever changing regulations and compliance requirements, pharmaceutical manufacturers are increasingly challenged in effectively managing information about their channels, customers, sales, and discounts. NCPDP, a not-for-profit ANSI-Accredited Standards Development Organization, has developed various standards and data solutions that can facilitate improved information management for manufacturers. NCPDP work groups work on standards to improve pharmaceutical manufacturer rebate processing, formulary and benefit information, pharmaceutical pedigree & traceability, and product identification among others. In addition, NCPDP’s data products such as dataQ® 3.0 and HCIdea® 3.0 can assist manufacturers in better managing their pharmacy and prescriber databases.
[Back to Agenda]
|
Marc Allgood, Pharm.D. (co-presenter)
, SUPERVALU, Inc.
Title: Director, Pharmacy Systems and Process Redesign
Presentation Title: ePrescribing of Controlled Substances: The Real World
Track Date: 5/9/2012 9:15:00 AM
Marc Allgood is currently the director of pharmacy systems and process redesign at SUPERVALU. He has 28 years of experience in the grocery and retail pharmacy industries. For the last 11 years, he has been in corporate management, supervising the support and development of the proprietary pharmacy management systems of one of the larger retail grocery and pharmacy chains.
Presentation Summary:
The Drug Enforcement Agency (DEA) published the Interim Final Rule (IFR) for ePrescribing of Controlled Substances (EPCS) over two years ago. Since that original publication thousands of hours from EPCS adopting organizations have been put into analysis, development, implementation, certification, and third party auditing to meet the requirements outlined by the DEA. This session will provide an overview of the industry experience implementing to meet the IFR and its impacts on the industry; ePrescribing systems, prescribers, pharmacists to enable all prescribing to occur electronically – and what we have seen to date for adoption, workflow and impacts.
[Back to Agenda]
|
Mary Jo Carden, R.Ph., Esq.
, Consultant
Title: Independent Consultant
Presentation Title: Critical Changes in Federal Health Care Privacy and Security Rules: What Payers and Pharmacies Need to Know to Comply
Track Date: 5/9/2012 10:30:00 AM
Mary Jo Carden is currently an independent consultant and previously served as director of federal regulatory affairs for Medco Health Solutions, Inc. where she focused on regulatory affairs; including health care reform, Medicare Part D, and other federal regulatory issues impacting Medco’s pharmacy benefit management company and other business units, including specialty pharmacy. Prior to her position at Medco, she was the president and founder of Carden & Associates, a boutique healthcare policy and advocacy firm founded in 2006. Carden previously served as principal of Dumbarton Group and Associates, LLC, a policy and advocacy firm she co-founded in 2003. Prior to her consulting experience, she held positions for eight years with the American Society of Consultant Pharmacists (ASCP), including director of government affairs and practiced community pharmacy. Carden also holds the position of assistant adjunct professor at the University of Florida College of Pharmacy and was previously an associate adjunct professor at Shenandoah University, Bernard J. Dunn School of Pharmacy. She has specialized knowledge and expertise in healthcare policy and regulatory issues including the Medicare Part D and B programs and other public and private pharmacy reimbursement programs; medication therapy management programs; controlled substance issues; and health information technology and privacy. Carden holds a Bachelor of Science in pharmacy degree from University of Pittsburgh School of Pharmacy and a Juris Doctor degree from the Catholic University of America in Washington, DC. She is admitted to the state bar of Maryland and is licensed as a pharmacist in the Commonwealth of Virginia..
Presentation Summary:
Protecting patient health information is a critical business function that pharmacists and pharmacies face on a regular basis. As more health care information is maintained in electronic systems, business and patients are vulnerable to hacking attacks and other invasions of health care privacy. Federal regulations first approved by HIPAA and then updated in 2009 under the Health Information Technology for Economic and Clinical Health (HITECH) Act to protect patient privacy continue to evolve and become more stringent. Health care providers and their business trading partners are increasingly subject to federal fines and penalties for noncompliance. Recently, the federal government announced a contract with a national audit firm to evaluate health care entities’ regulatory compliance. Pharmacists and pharmacies must understand that simply complying with federal and state privacy regulations is not sufficient to protect patient information or to provide continuity of operations. Health care entities must ensure that their electronic systems provide sufficient protection for patient data, provide assurance of operational continuity and that policies and procedures are in place to assess vulnerabilities and manage system attacks.
[Back to Agenda]
|
Thursday, May 10, 2012
Russ Stolnack
, Comedian
Title: Russ T. Nailz
Presentation Title: Breakfast Speaker
Track Date: 5/10/2012 8:00:00 AM
Russ Stolnack is well known by his nickname Russ T. Nailz. After years as radio morning man and TV news reporter, he is back on the air using his nickname again. Russ T. Nailz is a correspondent for the FOX Business Channel and co-hosts “The Big Show”, a nationally-syndicated money talk radio show, with partner Bob “Sully” Sullivan.
He joined the live comedy explosion in the late 70’s developing his comedic timing and classic routines. Today he delivers personalized comedy on platforms of all types. “Investing in Laughter Pays BIG Dividends”, his humorous presentation, highlights the value of humor in our lives.
You can find Stolnack at association luncheons or on a Las Vegas stage, a corporate meeting or an annual fundraiser. Wherever he is, Stolnack is funny. He is also part owner of AuctionHelp.com and delivers a very entertaining auction experience. Master of Ceremonies duties are often put in Russ’ hands too. His accomplishments include six regional Emmy awards, a Cable ACE Award and on his first appearance on the NSA platform, winning “The National Speakers Association Comedy Idol Contest”.
Presentation Summary:
Stolnack will entertain you during the closing breakfast.
[Back to Agenda]
|
NCPDP thanks our 2012 Annual Conference Web Pages Sponsor:
|